Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults

Infection and Immunity

Volumn 66, Issue 8, 1998, Pages 3796-3801

  He, Qiushui ^a,b   Tran Minh, Nhu Nguyen ^a   Edelman, Kati ^a,c   Viljanen, Matti K ^a,b   Arvilommi, Heikki ^a,b   Mertsola, Jussi ^a,b,c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Department of Medical Microbiology   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HEMAGGLUTININ; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PERTUSSIS TOXIN;

ARTICLE; BORDETELLA PERTUSSIS; CELLULAR IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MESSENGER RNA SYNTHESIS; PERTUSSIS; PRIORITY JOURNAL;

EID: 2642611922     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.8.3796-3801.1998     Document Type: Article

References (41)

1. Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events. Lancet i:955-960.
2. Ausiello, C. M., F. Urbani, A. la Sala, R. Lande, and A. Cassone. 1997. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccine. Infect. Immun. 65:2168-2174.
3. Bromberg, K., G. Tannis, and P. Steiner. 1991. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect. Immun. 59:4715-4719.
4. Caceres-Dittmar, G., F. J. Tapia, M. A. Sanchez, M. Yamamura, K. Uyemura, R. L. Modlin, B. R. Bloom, and J. Convit. 1993. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin. Exp. Immunol. 91:500-505.
5. Cattaneo, L. A., G. W. Reed, D. H. Haase, M. J. Wills, and K. M. Edwards. 1996. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J. Infect. Dis. 173:1256-1259.
6. Centers for Disease Control and Prevention. 1995. Pertussis - United States, January 1992-June 1995. Morbid. Mortal. Weekly Rep. 44:525-529.
7. Cherry, J. D., P. A. Brunell, G. S. Golden, and D. T. Karzon. 1988. Report of the task force on pertussis and pertussis immunization - 1988. Pediatrics 81(Suppl.):939-984.
8. Christie, C. D. C., M. L. Marx, C. D. Marchant, and S. F. Reising. 1994. The 1993 epidemic of pertussis in Cincinnati: resurgence of disease in a highly immunized population of children. N. Engl. J. Med. 331:16-21.
9. De Magistris, M. T., M. Romand, S. Nuti, R. Rappuoli, and A. Tagliabue. 1988. Dissecting human T cell responses against Bordetella species. J. Exp. Med. 168:1351-1362.
10. Di Tommaso, A., M. T. De Magistris, M. Bugnoli, I. Marsili, R. Rappuoli, and S. Abrignani. 1994. Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing. Infect. Immun. 62: 1830-1834.
11. Edwards, K. M., and M. D. Decker. 1996. Acellular pertussis vaccines for infants. N. Engl. J. Med. 155:74-76.
12. Edwards, K. M., B. D. Meade, M. D. Decker, G. F. Reed, M. B. Rennels, M. C. Steinhoff, E. L. Anderson, J. A. Englund, M. E. Pichichero, M. A. Deloria, and A. Deforest. 1995. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96(Suppl.):548-557.
13. Ewanowich, C. A., A. R. Melton, A. A. Weiss, R. K. Sherburne, and M. S. Peppler. 1989. Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect. Immun. 57:2698-2704.
14. Friedman, R. L., K. Nordensson, L. Wilson, E. T. Akporiaye, and D. E. Yocum. 1992. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect. Immun. 60:4578-4585.
15. Gearing, A. J., C. R. Bird, K. Redhead, and M. Thomas. 1989. Human cellular immune responses to Bordetella pertussis infection. FEMS Microbiol. Immunol. 1:205-211.
16. Greco, D., S. Salmaso, P. Mastrantonio, M. Guiliano, A. E. Tozzi, A. Anemona, M. L. Ciofi Degli Atti, A. Giammanco, P. Panei, W. C. Blackwelder, D. L. Klein, S. G. F. Wassilak, and the Progetto Pertosse Working Group. 1996. A controlled trial of two acellular vaccines and on whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
17. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
18. He, Q., G. Schmidt-Schläpfer, M. Just, H. C. Matter, S. Nikkari, M. K. Viljanen, and J. Mertsola. 1996. Impact of polymerase chain reaction on clinical pertussis research: Finnish and Swiss experiences. J. Infect. Dis. 174: 1288-1295.
19. He, Q., M. K. Viljanen, S. Nikkari, R. Lyytikainen, and J. Mertsola. 1994. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J. Infect. Dis. 170:873-877.
20. He, Q., M. K. Viljanen, R.-M. Ölander, H. Bogaerts, D. D. Grave, O. Ruuskanen, and J. Mertsola. 1994. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. J. Infect. Dis. 170:705-708.
21. Kimura, A., K. T. Mountzouros, D. A. Relman, S. Falkow, and J. L. Cowell. 1990. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect. Immun. 58:7-16.
22. Leung, J. C. K., C. K. W. Lai, Y. L. Chui, R. T. H. Ho, C. H. S. Chan, and K. N. Lai. 1992. Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaemagglutinin. Clin. Exp. Immunol. 90:147-153.
23. Melby, P. C., B. J. Darnell, and V. V. Tryon. 1993. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J. Immunol. Methods 159:235-244.
24. Mills, K. H., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
25. Mink, C. M., J. D. Cherry, P. Christenson, K. Lewis, E. Pineda, D. Shlian, J. A. Dawson, and D. A. Blumberg. 1992. A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. 14:464-471.
26. Nelson, J. D. 1978. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am. J. Dis. Child. 132:371-373.
27. Peppoloni, S., L. Nencioni, A. Di Tommaso, A. Tagliabue, P. Parronchi, S. Romagnani, R. Rappuoli, and M. T. De Magistris. 1991. Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Infect. Immun. 59:3768-3773.
28. Petersen, J. W., P. Andersen, P. H. Ibsen, C. Capiau, C. H. Wachmann, K. Haslov, and I. Heron. 1993. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine 11:463-472.
29. Podda, A., L. Nencioni, T. De Magistris, A. Di Dommaso, P. Bossu, S. Nuti, P. Pileri, S. Peppoloni, M. Bugnoli, P. Ruggiero, I. Marsili, A. D'Errico, A. Tagliabue, and R. Rappuoli. 1990. Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J. Exp. Med. 172:861-868.
30. Redhead, K., J. Watkins, A. Barhard, and K. H. G. Mills. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:3190-3198.
31. Robertson, P. W., H. Goldberg, B. H. Jarvie, D. D. Smith, and L. R. Whybin. 1987. Bordetella pertussis infection: a cause of persistent cough in adults. Med. J. Aust. 147:522-525.
32. Romagnani, S. 1995. Biology of human Th1 and Th2 cells. J. Clin. Immunol. 15:121-129.
33. Ruuskanen, O., A. Noel, A. Putto-Laurila, J. Petre, C. Capiau, A. Delem, D. Vandevoorde, E. Simoen, D. E. Teuwen, H. Bogaerts, and F. E. Andre. 1991. Development of an acellular pertussis vaccine and its administration as a booster in healthy adults. Vaccine 9:117-121.
34. Ryan, M., G. Murphy, L. Gothefors, L. Nilsson, J. Storsaeter, K. H. G. Mills. 1997. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175:1246-1250.
35. Sato, H., and Y. Sato. 1984. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin and filamentous hemagglutinin, with mouse protectivity in an intracerebral or aerosol challenge system. Infect. Immun. 46:415-421.
36. Saukkonen, K., C. Cabellos, M. Burroughs, S. Prasad, and E. Tuomanen. 1991. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1143-1149.
37. Shahin, R. D., M. J. Brennan, Z. M. Li, B. D. Meade, and C. R. Manclark. Characterization of the protective capacity and immunogenicity of the 69 KD outer membrane protein of Bordetella pertussis. J. Exp. Med. 171:63-73.
38. Tanaka, J., M. Imamura, N. Kasai, N. Masauzi, A. Matsuura, H. Ohizumi, K. Morii, Y. Kiyama, T. Naohara, M. Saitho, T. Higa, K. Honke, S. Gasa, K. Sakurada, and T. Miyazaki. 1993. Cytokine gene expression in peripheral blood mononuclear cells during graft-verse-host disease after allogeneic bone marrow transplantation. Br. J. Haematol. 85:558-565.
39. Tomoda, T., H. Ogura, and T. Kurashige. 1991. Immune responses to Bordetella pertussis infection and vaccination. J. Infect. Dis. 163:559-563.
40. Wortis, N., P. M. Strebel, M. Wharton, B. Bardenheier, and I. R. B. Hardy. 1996. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics 97:607-612.
41. Zepp, F., M. Knuf, P. Habermehl, H. J. Schmitt, C. Rebsch, P. Schmidtke, R. Clemens, and M. Slaoui. 1996. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect. Immun. 64:4078-4084.